Evelo Biosciences Sees Unusually Large Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of some unusual options trading activity on Wednesday. Stock investors bought 1,885 put options on the company. This is an increase of approximately 1,101% compared to the average volume of 157 put options.

Hedge Funds Weigh In On Evelo Biosciences

A hedge fund recently raised its stake in Evelo Biosciences stock. Vanguard Group Inc. lifted its stake in shares of Evelo Biosciences, Inc. (NASDAQ:EVLO) by 129.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 357,711 shares of the company’s stock after purchasing an additional 201,815 shares during the quarter. Vanguard Group Inc. owned about 1.88% of Evelo Biosciences worth $1,402,000 at the end of the most recent reporting period. 0.31% of the stock is currently owned by hedge funds and other institutional investors.

Evelo Biosciences Stock Performance

The firm’s 50 day moving average price is $0.03 and its two-hundred day moving average price is $0.05. Evelo Biosciences has a 1 year low of $0.00 and a 1 year high of $13.93.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.